ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 118 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $66 | -99.4% | 3,945 | +352.9% | 0.00% | – |
| Q3 2022 | $12,000 | -97.7% | 871 | -95.6% | 0.00% | – |
| Q1 2022 | $531,000 | +126.0% | 19,710 | +209.4% | 0.00% | – |
| Q4 2021 | $235,000 | +739.3% | 6,371 | +694.4% | 0.00% | – |
| Q3 2021 | $28,000 | -60.0% | 802 | -61.3% | 0.00% | – |
| Q2 2021 | $70,000 | -82.2% | 2,075 | -78.2% | 0.00% | -100.0% |
| Q1 2021 | $393,000 | +934.2% | 9,535 | +971.3% | 0.00% | – |
| Q4 2020 | $38,000 | +1166.7% | 890 | +959.5% | 0.00% | – |
| Q2 2020 | $3,000 | -93.0% | 84 | -97.4% | 0.00% | – |
| Q1 2020 | $43,000 | -70.1% | 3,224 | -75.7% | 0.00% | – |
| Q4 2019 | $144,000 | +13.4% | 13,292 | +7.0% | 0.00% | – |
| Q3 2019 | $127,000 | +477.3% | 12,420 | +413.0% | 0.00% | – |
| Q2 2019 | $22,000 | – | 2,421 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
| DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
| One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
| Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
| ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
| EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
| Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
| MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
| Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |